Syntara (ASX: SNT) Share Price and News

Price

$0.03

Movement

0.00 (0.0)

as at 5 Nov 12:15pm (20 mins delayed)

52 Week Range

$0.023 - $0.095

 
1 Year Return

-28.57%

Syntara Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

$0.03

Day Change

0.00 (0.0)

52 Week Range

$0.023 - $0.095

Yesterday's Close

$0.03

Today's Open

$0.03

Days Range

$0.03 - $0.0305

Volume

1,485,480

Avg. Volume (1 month)

1,780,094

Turnover

$44,595

as at 5 Nov 12:15pm

  • Syntara (ASX: SNT)
    Latest News

    medical asx share price represented by doctor giving thumbs up
    Share Market News

    Why the Pharmaxis (ASX:PXS) share price jumped 6% today

    The Pharmaxis Ltd (ASX: PXS) share price is up 6% during early afternoon trade. We look at the announcement driving…

    Read more »

    Share Market News

    Why the Pharmaxis (ASX:PXS) share price has rocketed up 48% today

    The Pharmaxis share price has shot up by 47.73% this morning after positive news about the product pipeline and short…

    Read more »

    Healthcare Shares

    ASX stock of the day: Pharmaxis share price surges 8% as milestone payment brought forward

    The Pharmaxis share price has surged 7% today after the company announced a US$7 million payment milestone had been brought…

    Read more »

    a woman
    Share Market News

    Is the Starpharma share price a buy?

    The Starpharma Holdings Limited (ASX: SPL) share price has gained 50% since the end of December 2018. Is it a…

    Read more »

    a woman
    Investing

    Warning: Every investor should read this before buying speculative biotech companies

    You could lose your shirt investing in companies like Innate Immunotherapeutics Ltd (ASX:IIL).

    Read more »

    a woman
    Investing

    This high-risk sector is one ALL new investors should avoid

    Australia's fledging biotech sector, filled with the likes of Cynata Therapeutics Ltd (ASX:CYP) and Pharmaxis Ltd (ASX:PXS) is not for…

    Read more »

    a woman
    Investing

    Revealed: This under-the-radar biotech has blockbuster potential

    Pharmaxis Ltd. (ASX:PXS) completes recruitment for Phase III cystic fibrosis trial.

    Read more »

    a woman
    Investing

    Here's why Prima Biomed Limited skyrocketed 59% today

    Prima Biomed Limited (ASX:PRR) isn't the only biotech exploding recently, with Pharmaxis Ltd. (ASX:PXS) and Sirtex Medical Limited (ASX:SRX) on…

    Read more »

    a woman
    Investing

    Here's why Pharmaxis Ltd. skyrocketed 60% today

    Pharmaxis Ltd. (ASX:PXS) shares gained more than 60% today, compared to a 1.1% decline for the ALL ORDINARIES (Index:^AXAO) (ASX:XAO).

    Read more »

    a woman
    Investing

    Here's why Pharmaxis Ltd. shares are soaring today

    Pharmaxis Ltd (ASX:PXS) is just one of Australia's biotech stocks bouncing today, with its shares up nearly 65%!

    Read more »

    a woman
    Investing

    6 stocks smashed on the ASX today

    The All Ordinaries closes flat, despite a strong start to the day

    Read more »

    a woman
    Investing

    4 stocks soaring on the ASX today

    S&P/ALL Ordinaries closes flat, but these four jumped more than 11%

    Read more »

    SNT ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size

    About Syntara

    Pharmaxis Ltd. is a pharmaceutical research company, which engages in the development and commercialization of healthcare products for fibrotic and inflammatory diseases. Its respiratory products include bronchitol and aridol. The company was founded by Brett Charlton and William B. Cowden on May 29, 1998 and is headquartered in Sydney, Australia.

    Profile

    since

    Note